| Primary |
| Bipolar Disorder |
13.9% |
| Depression |
11.4% |
| Schizophrenia |
11.4% |
| Product Used For Unknown Indication |
10.3% |
| Psychotic Disorder |
9.1% |
| Bipolar I Disorder |
7.0% |
| Schizoaffective Disorder |
6.4% |
| Anxiety |
4.4% |
| Insomnia |
4.1% |
| Major Depression |
3.2% |
| Agitation |
3.1% |
| Hypertension |
2.6% |
| Mania |
2.6% |
| Schizophrenia, Paranoid Type |
2.1% |
| Affective Disorder |
2.0% |
| Dementia |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Post-traumatic Stress Disorder |
1.3% |
| Bipolar Ii Disorder |
1.1% |
| Constipation |
1.1% |
|
| Completed Suicide |
22.0% |
| Drug Toxicity |
7.5% |
| Suicide Attempt |
5.5% |
| Overdose |
5.2% |
| Tachycardia |
5.2% |
| Respiratory Arrest |
4.6% |
| Neutropenia |
4.3% |
| Pulmonary Embolism |
4.3% |
| Sedation |
4.3% |
| Weight Increased |
4.3% |
| Thrombocytopenia |
4.0% |
| Neuroleptic Malignant Syndrome |
3.8% |
| Somnolence |
3.5% |
| Toxicity To Various Agents |
3.5% |
| Vomiting |
3.5% |
| Death |
3.2% |
| Intentional Overdose |
3.2% |
| Product Substitution Issue |
3.2% |
| Suicidal Ideation |
2.6% |
| Drug Ineffective |
2.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
30.0% |
| Product Used For Unknown Indication |
22.5% |
| Depression |
9.4% |
| Bipolar Disorder |
5.5% |
| Anxiety |
4.4% |
| Insomnia |
4.2% |
| Schizophrenia |
3.3% |
| Psychotic Disorder |
3.0% |
| Bipolar I Disorder |
2.6% |
| Feeling Abnormal |
2.0% |
| Frustration |
2.0% |
| Self Injurious Behaviour |
2.0% |
| Schizoaffective Disorder |
1.7% |
| Major Depression |
1.5% |
| Agitation |
1.4% |
| Completed Suicide |
1.0% |
| Hypertension |
1.0% |
| Suicide Attempt |
1.0% |
| Bipolar Ii Disorder |
0.8% |
| Affective Disorder |
0.7% |
|
| Completed Suicide |
19.7% |
| Respiratory Arrest |
12.9% |
| Death |
7.7% |
| Suicide Attempt |
5.0% |
| Toxicity To Various Agents |
5.0% |
| Weight Increased |
4.8% |
| Cardio-respiratory Arrest |
4.6% |
| Suicidal Ideation |
4.6% |
| Poisoning |
4.5% |
| Overdose |
4.1% |
| Drug Toxicity |
3.9% |
| Neuroleptic Malignant Syndrome |
3.5% |
| Intentional Drug Misuse |
2.9% |
| Colitis Ischaemic |
2.8% |
| Tachycardia |
2.7% |
| Vomiting |
2.6% |
| Serotonin Syndrome |
2.3% |
| Somnolence |
2.3% |
| Neutropenia |
2.1% |
| Poisoning Deliberate |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.9% |
| Product Used For Unknown Indication |
22.4% |
| Depression |
8.3% |
| Schizophrenia |
6.7% |
| Bipolar Disorder |
4.5% |
| Schizophrenia, Paranoid Type |
3.3% |
| Parkinson's Disease |
3.2% |
| Hiv Infection |
2.9% |
| Insomnia |
2.8% |
| Hepatitis C |
2.7% |
| Pain |
2.7% |
| Psychotic Disorder |
2.3% |
| Anxiety |
2.0% |
| Hypertension |
1.5% |
| Constipation |
1.4% |
| Mental Disorder |
1.4% |
| Rheumatoid Arthritis |
1.2% |
| Diabetes Mellitus |
1.0% |
| Back Pain |
0.9% |
| Dementia Alzheimer's Type |
0.8% |
|
| Vomiting |
9.4% |
| Weight Increased |
9.2% |
| Tremor |
8.8% |
| Weight Decreased |
7.1% |
| White Blood Cell Count Decreased |
6.9% |
| Somnolence |
6.3% |
| Suicide Attempt |
5.5% |
| Pancreatitis |
5.3% |
| Granulocytopenia |
5.1% |
| Suicidal Ideation |
4.5% |
| Metabolic Disorder |
3.5% |
| Pyrexia |
3.5% |
| White Blood Cell Count Increased |
3.5% |
| Pneumonia |
3.3% |
| Renal Failure Acute |
3.3% |
| Neuroleptic Malignant Syndrome |
3.1% |
| Vision Blurred |
3.1% |
| Tachycardia |
2.9% |
| Death |
2.7% |
| Diabetes Mellitus |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
18.1% |
| Drug Use For Unknown Indication |
14.5% |
| Bipolar Disorder |
8.9% |
| Depression |
7.1% |
| Psychotic Disorder |
6.3% |
| Schizoaffective Disorder |
5.6% |
| Hiv Infection |
5.4% |
| Schizophrenia |
4.9% |
| Cardiac Failure |
4.0% |
| Lower Respiratory Tract Infection |
3.6% |
| Abnormal Behaviour |
2.9% |
| Hyperglycaemia |
2.7% |
| Thyroid Disorder |
2.7% |
| Affective Disorder |
2.5% |
| Pain |
2.2% |
| Drug Dependence |
2.0% |
| Insomnia |
2.0% |
| Mental Disorder |
2.0% |
| Agitation |
1.3% |
| Drug Exposure During Pregnancy |
1.3% |
|
| Drug Interaction |
15.5% |
| Drug Level Increased |
13.1% |
| Hyperprolactinaemia |
7.1% |
| Respiratory Failure |
6.0% |
| Hypotension |
4.8% |
| Neutropenia |
4.8% |
| Parkinson's Disease |
4.8% |
| Residual Urine Volume |
4.8% |
| Rhabdomyolysis |
4.8% |
| Sedation |
4.8% |
| Torticollis |
4.8% |
| Urinary Retention |
4.8% |
| Suicidal Ideation |
3.6% |
| Drug Level Decreased |
2.4% |
| Hyperammonaemia |
2.4% |
| Mental Impairment |
2.4% |
| Parkinsonism |
2.4% |
| Psychotic Disorder |
2.4% |
| Respiratory Depression |
2.4% |
| Serotonin Syndrome |
2.4% |
|
